-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Bosheng Medical Devices Sets Sail Overseas, Achieving China’s First Export of Intravenous Infusion Tubing
Category:
发布时间：2025-01-02
【概要描述】
“Bosheng Medical Devices Embarks on a Global Expansion Strategy” and “Shisi Pharmaceutical Group’s Bosheng Medical Devices Achieves China’s First Export of 12,000 Meters of Intravenous Infusion Tubing”—on the morning of December 31, within the eastern factory area of Jiangsu Bosheng Medical New Materials Co., Ltd., a red banner hanging from a container truck stood out vividly in the sunlight. Pallets upon pallets of meticulously packaged intravenous infusion tubing bearing the Bosheng Medical Devices logo were being loaded onto the vehicle, soon to cross borders and enter overseas markets.
“Bosheng Medical Materials Embarks on a Global Expansion Strategy” and “Shisi Pharmaceutical Group’s Bosheng Medical Materials Achieves China’s First Export of 12,000 Meters of Intravenous Infusion Tubing”—on the morning of December 31, within the eastern factory area of Jiangsu Bosheng Medical New Materials Co., Ltd., a red banner hanging from a container truck stood out vividly in the sunlight. Pallets upon pallets of meticulously packaged intravenous infusion tubing bearing the Bosheng Medical Materials logo were being loaded onto the vehicle, soon to cross borders and enter overseas markets.
“To ensure the successful completion of the inaugural export shipment, the company has meticulously planned and rigorously coordinated every stage, from production to delivery,” said the head of Bosheng Medical Devices, who was on-site overseeing operations. “From the selection of raw materials and stringent oversight of each production step to final product inspection, we have rigorously implemented quality assurance measures to guarantee that our export products can stand up to the scrutiny of international markets.”
“This marks the first-ever export of our infusion tubing products, a milestone of great significance for Bosheng Medical Devices,” said the company’s head. Infusion tubing is another key new product developed following clean-free rubber stoppers, plunger cores for pen-type injectors, insulin pads, coated rubber stoppers, and blood-collection-device rubber stoppers. The successful bulk export of infusion tubing will further accelerate the establishment of an integrated “three-pronged” business model encompassing rubber stoppers, membrane materials, and tubing.
In recent years, Bosheng Medical Materials has focused on the R&D and manufacturing of novel pharmaceutical packaging materials, continuously advancing new-product development and technological upgrades while steadfastly implementing an innovation-driven development strategy and enhancing its capacity for original innovation. In particular, with regard to product innovation, the company has adhered to a R&D approach centered on “expanding product variety, elevating performance levels, and strengthening quality and efficiency,” vigorously reinforcing fundamental, innovative, and forward-looking research on rubber stoppers, film materials, tubing, and cutting-edge medical packaging materials. It has maintained deep engagement in the high-precision, high-end medical packaging sector, relentlessly explored frontier technologies in pharmaceutical packaging, and strived to establish itself as a leading hub of innovation. As one of the key R&D projects undertaken by the Bosheng Packaging Materials Research Institute since its establishment, the infusion tubing underwent nearly a year of refinement and validation before successfully obtaining registration with the Center for Drug Evaluation of the National Medical Products Administration in September 2024, thereby laying a solid foundation for capturing opportunities in both domestic and international markets.
The head of Bosheng Medical Devices stated, “We will take this as an opportunity to steadfastly advance our overseas expansion strategy, continuously increase R&D investment, enhance our product innovation capabilities, and steadily strengthen the company’s international competitiveness, so that more ‘Made in China’ pharmaceutical packaging materials can go global and contribute to the internationalization of China’s pharmaceutical packaging materials industry.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091